Handbook of polymers for pharmaceutical technologies . Volume 3 Biodegradable polymers / / edited by Vijay Kumar Thakur and Manju Kumari Thakur

• Record Nr.: UNINA9910819348103321
• Pubbl/distr/stampa: Hoboken, New Jersey ; ; Salem, Massachusetts : , : Scrivener Publishing : , : Wiley, , 2015; ©2015
• ISBN: 1-119-04143-0; 1-119-04145-7; 1-119-04144-9
• Descrizione fisica: 1 online resource (727 p.)
• Disciplina: 572.33
• Soggetti: Polymers - Therapeutic use; Polymers in medicine; Pharmaceutical technology
• Lingua di pubblicazione: Inglese
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Note generali: Description based upon print version of record.
• Nota di bibliografia: Includes bibliographical references at the end of each chapters and index.
• Nota di contenuto: ""Half Title page""; ""Title page""; ""Copyright page""; ""Dedication""; ""Preface""; ""Chapter 1: Bioactive Polysaccharides of Vegetable and Microbial Origins: An Overview""; ""1.1 Introduction""; ""1.2 Anticarcinogenic Polysaccharides""; ""1.3 Anti-inflammatory/Immunostimulating Polysaccharides""; ""1.4 Antiviral Polysaccharides""; ""1.5 Antioxidant Polysaccharides""; ""1.6 Other Biotechnological Applications""; ""1.7 Conclusions and Future Perspectives""; ""Acknowledgments""; ""References""; ""Chapter 2: Chitosan: An Emanating Polymeric Carrier for Drug Delivery""; ""2.1 Introduction""; ""2.2 Preparation of Chitosan""""2.3 Physicochemical Properties of Chitosan""; ""2.4 Biological Activities of Chitosan""; ""2.5 Pharmaceutical Applications of Chitosan""; ""2.6 Functionalization of Chitosan""; ""2.7 Conclusion and Future Perspectives""; ""References""; ""Chapter 3: Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications""; ""3.1 Introduction""; ""3.2 The Fungal Cell""; ""3.3 ; Polysaccharides Produced by Fungi""; ""3.4 Production and Extraction of Polysaccharides from Fungi""; ""3.5 Fungal Polysaccharides in Biomedical and Pharmaceutical Applications""""3.6 Commercial Exploitation of Fungal Polysaccharides in Biomedical and Pharmaceutical Applications""; ""3.7 Conclusion and Future Perspective""; ""References""; ""Chapter 4: Environmentally Responsive Chitosan-based Nanocarriers (CBNs)""; ""4.1 Introduction""; ""4.2 Graft Copolymerized CBNs""; ""4.3 pH-Sensitive CBNs""; ""4.4 Thermosensitive CBNs""; ""4.5 pH-Sensitive and Thermosensitive CBNs""; ""4.6 pH- and Ionic-Sensitive CBNs""; ""4.7 Photosensitive CBNs""; ""4.8 Electrical-Sensitive CBNs""; ""4.9 Magneto-Responsive CBNs""""4.10 Chemo-Sensitive CBNs""; ""4.11 Biodegradation of Chitosan and Its Derivatives""; ""4.12 Toxicity of CBNs""; ""4.13 Conclusions and Future Perspectives""; ""References""; ""Chapter 5: Biomass Derived and Biomass Inspired Polymers in Pharmaceutical Applications""; ""5.1 Introduction""; ""5.2 Biodegradable Polymers in Biomedical Applications - Relevant Aspects""; ""5.3 Biodegradable Natural Polymers in Pharmaceutical Applications""; ""5.4 Micro- and Nanocrystalline Natural Polymers and Fibrils - General Regulative Considerations""; ""5.5 Concluding Remarks and Outlook""""References""; ""Chapter 6: Modification of Cyclodextrin for Improvement of Complexation and Formulation Properties""; ""Abbrevations:""; ""6.1 Introduction""; ""6.2 Cyclodextrin and Its Degradation""; ""6.3 Complexation by CDs and Release""; ""6.4 Modifications and Scope with Respect to Pharmaceutical Application""; ""6.5 Concluding Remarks""; ""Acknowledgements""; ""References""; ""Chapter 7: Cellulose-, Ethylene Oxide- and Acrylic-Based Polymers in Assembled Module Technology (Dome Matrix®)""; ""7.1 Dome Matrix® Technology""; ""7.2 Polymers for Controlled Drug Release""